Efficacy of rabdosia rubescens in the treatment of gingivitis

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 5, 2009, Pages 659-663

  Chen, Sui ^a   Liu, Jiarong ^a   Zhang, Handong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Drop pill; Gingivitis; Rabdosia rubescens; Tablet

Indexed keywords

HERBACEOUS AGENT;

ADULT; ARTICLE; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GINGIVITIS; HUMAN; MALE; MULTICENTER STUDY; PHYTOTHERAPY; RABDOSIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; GINGIVITIS; HUMANS; MALE; PHYTOTHERAPY; RABDOSIA; TREATMENT OUTCOME;

EID: 70350624803     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0525-2     Document Type: Article

References (25)

1. Li Q, Chen Z, Liu J, et al. Effect of oridonin on the hemodynamics in anaesthetized rabbits. Chin Pharm Bull (Chinese), 1993(1):53-55
2. Q. Li J. Liu Z. Chen, et al. 1994 Effect of oridonin on the hemodynamics in rabbits and its mechanism research J Norman Bethune Univ Med Sci (Chinese) 20 2 128 129
3. X.H. Su C.M. Dong W.L. Wang, et al. 2008 Dy namics research of main secondary metabolites accumulation in rabdosia rubescens tissue culture Zhongguo Zhong Yao Za Zhi (Chinese) 33 9 1080 1084
4. N. Feng P. Wu Q. Li, et al. 2008 Oridonin-loaded poly(epsilon- caprolactone)-poly (ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma J Drug Target 16 6 479 485 18604660 10.1080/10611860802102282 1:CAS:528:DC%2BD1cXotFejtb4%3D (Pubitemid 352015816)
5. I. Ikezoe S.S. Chen X.J. Tong, et al. 2003 Oridonin induces growth inhibition and apoptosis of a variety of human cancer cell Int J Oncol 23 4 1187 1193 12964003 1:CAS:528:DC%2BD3sXovV2nsrg%3D
6. Y. Cheng F. Qiu Y.C. Ye, et al. 2009 Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells FEBS J 276 5 1291 1306 19187231 10.1111/j.1742-4658.2008.06864.x 1:CAS:528:DC%2BD1MXivFensbg%3D
7. D. Li L.J. Wu S. Tashiro, et al. 2008 Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway J Asian Nat Prod Res 10 1-2 77 87 18058384 10.1080/10286020701273866 1:CAS:528:DC%2BD2sXhtl2isL3I (Pubitemid 350223221)
8. Y.F. Wang J.H. Jiang Q.R. Wang, et al. 2002 Antitumor and immunological activities of polysaccharides from rabdosia rubescens Chin J Pathophysiol (Chinese) 18 11 1341 1343 1:CAS:528:DC%2BD2cXhtFertLo%3D
9. Y.Q. Liu S. You S. Tashiro, et al. 2006 Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells Int Immunopharmacol 6 2 260 268 16399631 10.1016/j.intimp.2005.08.013 1:CAS:528:DC%2BD28XitFGkuw%3D%3D (Pubitemid 43052823)
10. Y.Q. Liu S. You S. Tashiro, et al. 2005 Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells J Pharmacol Sci 98 4 361 371 16079470 10.1254/jphs.FPJ05005X 1:CAS:528:DC%2BD2MXps1OmtLs%3D (Pubitemid 41297009)
11. Y. Zhang Y. Wang 1998 Effect of rebescensine A on removal of active free radicals Henan Med Res (Chinese) 8 2 100 104
12. X. Xu X.L. Zhang 2002 Study of Oridonin on antioxidation J Strait Pharm (Chinese) 16 6 28 31
13. S.M. Sagar D. Yance R.K. Wonq 2006 Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1 Curr Oncol 13 1 14 26 17576437 1:STN:280:DC%2BD2szmt1Whtg%3D%3D
14. L.S. Adams N.P. Seeram M.L. Hardy, et al. 2006 Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines Evid Based Complement Alternat Med 3 1 117 124 16550232 10.1093/ecam/nel001 (Pubitemid 43999659)
15. G.B. Zhou H. Kang L. Wang, et al. 2007 Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo Blood 109 8 3441 3450 17197433 10.1182/blood-2006-06-032250 1:CAS:528: DC%2BD2sXksFWhsrw%3D (Pubitemid 46572534)
16. Y.N. Yu Y.X. Yu 2002 One case-therapy of acute pharyngitis with Rabdosia rubescens Chin Remed Clin (Chinese) 2 3 l71
17. Z.Y. Feng F.L. Zhang X.J. Tian 2006 Observation for therapeutic effect of compound rabdosia rubescens toroche on cute pharyngitis and cute pharyngitis J Youjiang Med (Chinese) 34 6 599 601
18. Cao CF. Periodontics. 2nd ed. Beijing: People's Medical Publishing House, 2005,75-107
19. Zhuang ZY. Oral Science. 6th ed. Beijing: People's Medical Publishing House, 2004,54-72
20. Q. Li W.S. Feng 2003 The latest development of researches on the chemical constituents and pharmacological activity of rabdosia rubescens hara J Henan Univ Chin Med (Chinese) 18 6 31 33
21. H. Dai S.H. Liu X. Zhou, et al. 2008 Research progress of pharmacological actions and clinical application of rabdosia rubescens Sichuan J Physiol Sci (Chinese) 30 1 20 21
22. H.Y. Hua J.L. Zhu Q.X. Ye 2006 Experimental research on bacteriostatic effect of rabdosia rubescens drop pill and table in vitro and in vivo Chin Trad Herb Drug (Chinese) 37 Suppl 79 81
23. F.J. Song S.J. Wu J.J. Liang 2004 Study on antibacterial activity about isodon rubescens from badong J South-Central Univ Natl (Natural Science Edition) (Chinese) 23 4 9 11
24. X.Y. Duan Y.H. Wang 1997 Experimental research on bacteriostatic effect of compound rabdosia rubescens toroche in vitro J Henan col Trad Chin Med (Chinese) 12 6 38 39
25. Z.K. Xu 2007 Rabdosia rubescens expected to be the second taxol Modern Chin Med (Chinese) 9 8 43 45